We are live on ! Find out more
ARLZ

Aralez Pharmaceuticals Inc.
ARLZ

Delisted

ARLZ was delisted on the 20th of August, 2018.

90 hedge funds and large institutions have $108M invested in Aralez Pharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 90 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $1.68M

Holders
90
Holders Change
+90
Holders Change %
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
90
Increased
Reduced
Closed
Calls
$1.22M
Puts
$1.68M
Net Calls
-$456K
Net Calls Change
-$456K
Name Holding Trade Value Shares
Change
Change in
Stake
RCMC
26
Rubric Capital Management (Connecticut)
Connecticut
$843K +$1.22M +237,547 New
SM
27
Sabby Management
Florida
$839K +$1.22M +236,364 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$694K +$1.01M +195,369 New
BIM
29
BlackRock Investment Management
Delaware
$669K +$971K +188,310 New
Wells Fargo
30
Wells Fargo
California
$652K +$946K +183,470 New
Macquarie Group
31
Macquarie Group
Australia
$533K +$773K +150,000 New
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$461K +$669K +129,749 New
Millennium Management
33
Millennium Management
New York
$432K +$628K +121,817 New
PP
34
Prospector Partners
Connecticut
$401K +$582K +112,900 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$400K +$580K +112,574 New
TAM
36
Tocqueville Asset Management
New York
$359K +$521K +101,000 New
HVC
37
Healthcare Value Capital
New Jersey
$355K +$515K +100,000 New
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$342K +$496K +96,200 New
BCM
39
Bridgeway Capital Management
Texas
$331K +$480K +93,200 New
Westfield Capital Management
40
Westfield Capital Management
Massachusetts
$316K +$459K +89,000 New
Charles Schwab
41
Charles Schwab
California
$299K +$434K +84,100 New
IAM
42
Integre Asset Management
New York
$291K +$422K +81,841 New
Two Sigma Advisers
43
Two Sigma Advisers
New York
$289K +$420K +81,400 New
AA
44
ALPS Advisors
Colorado
$255K +$371K +71,930 New
TA
45
Teachers Advisors
New York
$233K +$338K +65,608 New
AllianceBernstein
46
AllianceBernstein
Tennessee
$224K +$325K +63,086 New
NFA
47
Nationwide Fund Advisors
Ohio
$216K +$313K +60,741 New
FSA
48
Franklin Street Advisors
North Carolina
$211K +$307K +59,500 New
GCP
49
GSA Capital Partners
United Kingdom
$210K +$306K +59,295 New
Simplex Trading
50
Simplex Trading
Illinois
$191K +$277K +53,835 New

ARLZ Hedge Fund Activity: Q1 2016 in Review

90 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Aralez Pharmaceuticals Inc. (ARLZ) for Q1 2016, worth a combined $108M.

Buyers outnumbered sellers: 90 funds opened new ARLZ positions and 0 closed out — a net gain of 90 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PAR Capital Management, opening a new position worth an estimated $27.7M.

  • 90 institutional investors held Aralez Pharmaceuticals Inc. (ARLZ) as of Q1 2016, up from 0 in Q4 2015.
  • Funds reported $108M of Aralez Pharmaceuticals Inc. stock for Q1 2016.
  • 90 funds opened new Aralez Pharmaceuticals Inc. positions in Q1 2016 and 0 closed out, a net change of +90 holders.
  • The largest Aralez Pharmaceuticals Inc. buyer in Q1 2016 was PAR Capital Management, an estimated $27.7M added.

Based on aggregated 13F filings for Q1 2016.